Mass spectrometry tissue imaging service, based on proprietary processes and exclusive technology licenses from Vanderbilt University and the University of Texas, provides insight into protein expression, disease progression and drug metabolism. Imaging Mass Spectrometry is a method that enables direct spectrometric analysis of tissues, yielding highly specific, spatially resolved molecular profiles of targeted regions. Data from these analyses may form prognostic or diagnostic markers of disease, or reveal potential therapeutic and toxic effects of drug compounds prior to clinical testing. The technology can also help pharmaceutical researchers determine the metabolic processing of new drug compounds and whether the compounds are successfully reaching targeted tissues. Protein Discovery, Inc. 865-521-7400 www.proteindiscovery.com